Adverse outcomes in study patients and controls
| Outcomes | Study group (n=30) | Case-matched controls (n=30) |
| Total adverse outcomes | 10 | 16 |
| Access device occlusion | 1 | 0 |
| Emergency room visits | 2 | 2 |
| Unplanned hospitalisation | 7 | 14 |
| PN-related hospitalisation | 3 | 3 |
| PN unrelated hospitalisation | 4 | 11 |
| Total hospital admissions | 11 | 20 |
| Single hospital admission | 3 | 8 |
| Double hospital admission | 4 | 5 |
| Triple hospital admission | 0 | 2 |
| Readmission rate | 0.13 | 0.23 |
| Hospitalisation rate per patient | 0.37 | 0.67 |
| Total hospital length of stay (LOS) days | 69 | 153 |
| Average LOS day | 6.27 | 7.65 |
Note. Study patients had fewer total adverse outcomes and unplanned hospitalisation than case-matched controls. Emergency department use was similar in both groups. Study group patients had a lower hospitalisation rate, readmission rate, total LOS and average LOS than case-matched controls.
PN, parenteral nutrition.